ArticleBiomedicines2022

Monoclonal Antibodies and Antivirals against SARS-CoV-2 Reduce the Risk of Long COVID: A Retrospective Propensity Score-Matched Case-Control Study.

Antonio Cimellaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.